You are here

HBV Vaccination & Liver Cancer Prevention Webinar

Join us for a webinar April 12th, 2022 with leading experts who will present on HBV Vaccination and Screening guidelines, liver cancer prevention, as well as address health disparities associated with vaccination uptake


ERIN CONNERS, PhD, MPH; Epidemiologist, CDC, Division of Viral Hepatitis

Dr. Erin Conners is an epidemiologist with the Division of Viral Hepatitis at CDC within the Prevention Branch. Her work focuses on the development of updated hepatitis B screening and testing guidelines as well as supporting interventions to improve the prevention of and care for people with hepatitis B infection.

CHARI COHEN, DrPH, MPH; Senior Vice President, Hepatitis B Foundation

Chari Cohen is Senior Vice President for the Hepatitis B Foundation. For the past 21 years, she has planned, implemented, and evaluated community programs and research projects focusing on reducing health disparities and improving health outcomes associated with hepatitis B and liver cancer. Her work focuses on improving awareness and knowledge, reducing stigma, and promoting hepatitis B testing and care. Dr. Cohen is co-chair of the national Hep B United coalition, co-founder and chair of Hep B United Philadelphia, co-founder and chair of CHIPO: Coalition Against Hepatitis for People of African Origin; and co-chair of the Hep Free PA coalition. She sits on the steering committee for the HBV Forum for Collaborative Research and serves as a member of the Patient Advocacy Group of the American Association for the Study of Liver Diseases (AASLD). Dr. Cohen is Professor at the Baruch S. Blumberg Institute, and adjunct faculty for Geisinger Commonwealth School of Medicine.

BRIAN McMAHON, MD; Medical and Scientific Director Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium

Brian J. McMahon MD is a clinical Hepatologist and the Scientific Program and Clinical Director of the Liver Disease and Hepatitis Program at the Alaska Native Medical Center in Anchorage, Alaska, and guest researcher at the Arctic Investigations Program of the CDC in Anchorage. He is a fellow in the AASLD and a Master in the American College of Physicians. He is a Clinical Professor of Medicine at the University of Washington and University of Alaska WWAMI Medical School. His program follows over 1200 Alaska Native Persons with chronic hepatitis B and 2400 with chronic hepatitis C throughout the State of Alaska. The hepatitis B program has already met all WHO 2030 goals for HBV. He conducts research on long-term outcome and management of chronic hepatitis B and C.


Topic: CCCNP Vaccine Preventable Workgroup: HBV Webinar

Time: Apr 12, 2022 04:00 PM Eastern Time (US and Canada)


Join Zoom Meeting


Meeting ID: 839 6192 1573

One tap mobile

+13017158592,,83961921573# US (Washington DC)

+13126266799,,83961921573# US (Chicago)


Dial by your location

        +1 301 715 8592 US (Washington DC)

        +1 312 626 6799 US (Chicago)

        +1 929 205 6099 US (New York)

        +1 253 215 8782 US (Tacoma)

        +1 346 248 7799 US (Houston)

        +1 669 900 6833 US (San Jose)

Meeting ID: 839 6192 1573

Find your local number: